ANI Pharmaceuticals Inc
NASDAQ:ANIP
ANI Pharmaceuticals Inc
Change in Working Capital
ANI Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
Change in Working Capital
$16.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Working Capital
-$94m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Working Capital
-$356m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Change in Working Capital
-$5m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
42%
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Working Capital
-$2.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-24%
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Working Capital
-$5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-33%
|
See Also
What is ANI Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
16.4m
USD
Based on the financial report for Mar 31, 2024, ANI Pharmaceuticals Inc's Change in Working Capital amounts to 16.4m USD.